pH-sensitive doxorubicin-tocopherol succinate prodrug encapsulated in docosahexaenoic acid-based nanostructured lipid carriers: An effective strategy to improve pharmacokinetics and reduce toxic effects-Reference-Cited by-同舟云学术

pH-sensitive doxorubicin-tocopherol succinate prodrug encapsulated in docosahexaenoic acid-based nanostructured lipid carriers: An effective strategy to improve pharmacokinetics and reduce toxic effects

Published:2021-12 Issue: Volume:144 Page:112373
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Lages Eduardo Burgarelli,Fernandes Renata Salgado,Andrade Marina Mol Sena,Paiyabhroma Nitchawat,de Oliveira Renata Barbosa,Fernandes Christian,Cassali Geovanni Dantas,Sicard Pierre,Richard Sylvain,Branco de Barros André Luís,Ferreira Lucas Antônio Miranda

Funder

Fundação de Amparo à Pesquisa do Estado de Minas Gerais

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference54 articles.

1. Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes;Zhao;Sci. Rep.,2017

2. Doxorubicin: the good, the bad and the ugly effect;Carvalho;Curr. Med. Chem.,2009

3. Doxorubicin: nanotechnological overviews from bench to bedside;Cagel;Drug Discov. Today,2017